Similar results have been reported in the ICI context for melanoma, in which responding tumors to different ICI treatments were characterized using a 1-NN statistic by proximity between proliferating antigen-experienced CD8+ T cells (CD45RO+Ki67+) and their closest cancer cell23. The gene discussed is CD8A; the disease is cancer.